Clinical Trial Update: Clinical Study on the Safety and Efficacy of CD7 CAR-T Cell in Patients With Relapsed/Refractory Acute Leukemia [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial evaluates the safety and efficacy of CD7 CAR-T cell therapy in relapsed/refractory acute leukemia. The study is in Phase 1/Phase 2 and curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia

Drugs mentioned

• CD7 CAR-T cell therapy

Snippet

Sponsor: The General Hospital of Western Theater Command | Conditions: Acute-Leukemia | Phase 1, Phase 2 | Status: RECRUITING